| 肺动脉高压的免疫调节治疗 |
| |
| 引用本文： | 刘明伟,李岚.肺动脉高压的免疫调节治疗[J].实用药物与临床,2011,14(1). |
| |
| 作者姓名： | 刘明伟 李岚 |
| |
| 作者单位： | 昆明市延安医院呼吸二科,昆明,650051 |
| |
| 摘 要： | 肺动脉高压是临床上常见的疾病,其发病机制尚未完全清楚。免疫因素在肺动脉高压的发病机制中起重要作用。免疫抑制疗法为肺动脉高压治疗提供了新的途径。本文就机体免疫紊乱对肺动脉高压的影响机制及其免疫调节治疗的临床应用及研究现状进行综述。
|
| 关 键 词： | 肺动脉高压 免疫机制 免疫细胞 免疫分子 |
Treatment status of immunotherapy for pulmonary arterial hypertension |
| |
| LIU Ming-wei,LI Lan.Treatment status of immunotherapy for pulmonary arterial hypertension[J].Practical Pharmacy and Clinical Remedies,2011,14(1). |
| |
| Authors: | LIU Ming-wei LI Lan |
| |
| Institution: | LIU Ming-wei,LI Lan(The Second Department of Respiratory Medicine,Yan'an Hospital,Kunming 650051,China) |
| |
| Abstract: | Pulmonary hypertension is a common disease,and the pathogenesis of it is not entirely clear.Immune factors play an important role in pathogenesis of pulmonary hypertension.The immunesuppressive therapy provides a new way for pulmonary hypertension treatment.This article summarizes the mechanisms and immunotherapy of pulmonary hypertension. |
| |
| Keywords: | Pulmonary arterial hypertension Immunologic mechanism Immune cell Immune molecules |
| 本文献已被 CNKI 万方数据 等数据库收录！ |
|
